Back to All Media
Jul 1, 2016
Aquaculture Exchange: Ron Stotish, AquaBounty Technologies
Ron Stotish is swamped. The CEO of AquaBounty Technologies
– the company that aims to be the first to produce a genetically modified (GM) farmed salmon for the marketplace – has been busier than usual in recent months, thanks in part to two major wins that should signal the end of a two-decade-long saga marked with rigorous reviews, media scrutiny and vehement opposition from public-interest advocacy groups.
The first win came in November 2015, when the U.S. Food and Drug Administration (FDA) approved the company’s application for the production, sale and consumption of its fast-growing AquAdvantage salmon. Then, in May, just as Stotish was preparing to present at the IntraFish Seafood Investors Forum at the Grand Hyatt in New York, the news broke that Health Canada had also approved the augmented Atlantic salmon for sale. Read article here